Skip to main content

Strong returns for AusCann investors

09/07/2018 - 15:57

SPECIAL REPORT: AusCann has benefited from a wave of interest in medicinal cannabis for pain relief to be the BN30’s top performer in shareholder returns for the year to June 30.

X

To read our articles you will need to either login or subscribe.